EcoDrugPlus

Cyclin Dependent Kinase 1

Ensembl ID : ENSVPAG00000012588
Gene Symbol: CDK1
1 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSVPAG00000009521
Gene Symbol: CDK2
1 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSVPAG00000002256
Gene Symbol: CDK6
1 Cross references
198 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSVPAG00000010834
Gene Symbol: CDK7
1 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSVPAG00000004820
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSVPAG00000008145
Gene Symbol: CYP19A1
1 Cross references
315 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSVPAG00000001298
Gene Symbol: CYP26A1
1 Cross references
207 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSVPAG00000002917
Gene Symbol: DHODH
1 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSVPAG00000001096
Gene Symbol: DPYD
1 Cross references
220 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSVPAG00000010817
Gene Symbol: DPP4
1 Cross references
282 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSVPAG00000001072
Gene Symbol: DDR2
1 Cross references
265 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSVPAG00000010850
Gene Symbol: DRD1
1 Cross references
261 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).